US5230888A
(en)
*
|
1982-05-06 |
1993-07-27 |
Massachusetts Institute Of Technology |
Production of neutralizing antibodies by polypeptide VP1 of enteroviruses and by oligopeptide fragments of polypeptide VP1
|
NZ207394A
(en)
*
|
1983-03-08 |
1987-03-06 |
Commw Serum Lab Commission |
Detecting or determining sequence of amino acids
|
DE3813821A1
(de)
*
|
1988-04-22 |
1989-11-02 |
Hoechst Ag |
Synthetische vakzine gegen die maul- und klauenseuche und verfahren zu deren herstellung
|
US5866363A
(en)
|
1985-08-28 |
1999-02-02 |
Pieczenik; George |
Method and means for sorting and identifying biological information
|
EP0251575B2
(de)
*
|
1986-06-17 |
2002-11-13 |
Chiron Corporation |
Hepatitis-Delta-Diagnostika und Impfstoffe, ihre Herstellung und Verwendung
|
US5919665A
(en)
*
|
1989-10-31 |
1999-07-06 |
Ophidian Pharmaceuticals, Inc. |
Vaccine for clostridium botulinum neurotoxin
|
US6730305B1
(en)
|
2000-05-08 |
2004-05-04 |
The Uab Research Foundation |
Nucleotide sequences encoding bovine respiratory syncytial virus immunogenic proteins
|
US5674978A
(en)
*
|
1990-09-21 |
1997-10-07 |
The Regents Of The University Of California |
Peptides derived from glutamic acid decarboxylase
|
ATE176239T1
(de)
*
|
1990-11-21 |
1999-02-15 |
Iterex Pharma Lp |
Synthese äquimolarer mischungen vielzähliger oligomere, speziell oligopeptidmischungen
|
US5243540A
(en)
*
|
1991-04-03 |
1993-09-07 |
The United States Of America As Represented By The Secretary Of The Army |
Computer-driven amino acid indexer for peptide synthesis
|
US5397703A
(en)
*
|
1992-07-09 |
1995-03-14 |
Cetus Oncology Corporation |
Method for generation of antibodies to cell surface molecules
|
US5512492A
(en)
*
|
1993-05-18 |
1996-04-30 |
University Of Utah Research Foundation |
Waveguide immunosensor with coating chemistry providing enhanced sensitivity
|
US5919712A
(en)
|
1993-05-18 |
1999-07-06 |
University Of Utah Research Foundation |
Apparatus and methods for multi-analyte homogeneous fluoro-immunoassays
|
US5677196A
(en)
*
|
1993-05-18 |
1997-10-14 |
University Of Utah Research Foundation |
Apparatus and methods for multi-analyte homogeneous fluoro-immunoassays
|
US5480971A
(en)
*
|
1993-06-17 |
1996-01-02 |
Houghten Pharmaceuticals, Inc. |
Peralkylated oligopeptide mixtures
|
US5846731A
(en)
*
|
1993-06-17 |
1998-12-08 |
Torry Pines Institute For Molecular Studies |
Peralkylated oligopeptide mixtures
|
US5380668A
(en)
*
|
1993-07-06 |
1995-01-10 |
University Of Utah Research Foundation |
Compounds having the antigenicity of hCG
|
US6287787B1
(en)
|
1993-11-24 |
2001-09-11 |
Torrey Pines Institute For Molecular Studies |
Dimeric oligopeptide mixture sets
|
US5645996A
(en)
*
|
1994-08-24 |
1997-07-08 |
Torrey Pines Institute For Molecular Studies |
Melittin-related polypeptides, mixture sets and libraries thereof
|
US5582997A
(en)
*
|
1994-08-24 |
1996-12-10 |
Torrey Pines Institute For Molecular Studies |
Lysine/leucine polypeptides, mixture sets and libraries thereof
|
US5747458A
(en)
*
|
1995-06-07 |
1998-05-05 |
Chiron Corporation |
Urokinase receptor ligands
|
US5756300A
(en)
*
|
1995-11-14 |
1998-05-26 |
Research Genetics, Inc. |
Oligodendrocyte-specific protein and method for diagnosing and treating disease
|
US6150136A
(en)
*
|
1995-11-14 |
2000-11-21 |
The Regents Of The University Of California |
Nucleotide sequence encoding oligodendrocyte-specific protein
|
US6323020B1
(en)
|
1996-08-23 |
2001-11-27 |
North Carolina State University |
Neutralization-sensitive epitopes of Cryptosporidium parvum
|
US20040161409A1
(en)
*
|
1997-07-25 |
2004-08-19 |
Kurtzman Gary J. |
Induction of immune response to antigens expressed by recombinant adeno-associated virus
|
US6710036B2
(en)
|
1997-07-25 |
2004-03-23 |
Avigen, Inc. |
Induction of immune response to antigens expressed by recombinant adeno-associated virus
|
CA2301942C
(en)
|
1997-08-27 |
2011-05-31 |
Chiron Corporation |
Molecular mimetics of meningococcal b epitopes
|
KR100879650B1
(ko)
|
1997-12-11 |
2009-01-20 |
유니버시티 오브 사스카췌완 |
돼지로부터의 이유후 다기관계작용성 소모 증후군 바이러스
|
US6369201B1
(en)
|
1998-02-19 |
2002-04-09 |
Metamorphix International, Inc. |
Myostatin multimers
|
US6500637B1
(en)
|
1998-03-31 |
2002-12-31 |
The Institute Of Physical And Chemical Research |
Neurogenesis inducing genes
|
US8206749B1
(en)
|
1999-02-26 |
2012-06-26 |
Novartis Vaccines And Diagnostics, Inc. |
Microemulsions with adsorbed macromolecules and microparticles
|
US9289487B2
(en)
*
|
1999-09-14 |
2016-03-22 |
Antigen Express, Inc. |
II-key/antigenic epitope hybrid peptide vaccines
|
US6432409B1
(en)
*
|
1999-09-14 |
2002-08-13 |
Antigen Express, Inc. |
Hybrid peptides modulate the immune response
|
US20030235594A1
(en)
*
|
1999-09-14 |
2003-12-25 |
Antigen Express, Inc. |
Ii-Key/antigenic epitope hybrid peptide vaccines
|
US20040092712A1
(en)
*
|
2000-03-31 |
2004-05-13 |
Shoji Furusako |
Tlr/cd14 binding inhibitor
|
US6686188B2
(en)
*
|
2000-05-26 |
2004-02-03 |
Amersham Plc |
Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle
|
US6656700B2
(en)
|
2000-05-26 |
2003-12-02 |
Amersham Plc |
Isoforms of human pregnancy-associated protein-E
|
EP1734050A3
(de)
|
2000-06-12 |
2012-12-05 |
University Of Saskatchewan |
Immunisation von Milchvieh mit GapC Protein gegen Streptococcusinfektion
|
US6783939B2
(en)
*
|
2000-07-07 |
2004-08-31 |
Alphavax, Inc. |
Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
|
AU2001296545A1
(en)
|
2000-10-02 |
2002-04-15 |
Chiron Corporation |
Methods of therapy for b-cell malignancies
|
ES2446984T3
(es)
|
2001-01-04 |
2014-03-11 |
University Of Saskatchewan |
Vacuna contra Escherichia coli enterohemorrágica
|
EP1351980B1
(de)
|
2001-01-18 |
2014-12-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Peptide zur aktivierung und inhibierung von delta-pkc
|
CA2658221C
(en)
|
2001-04-27 |
2012-11-27 |
Kyowa Hakko Kirin Co., Ltd. |
Anti-cd40 monoclonal antibody
|
EP2332573A1
(de)
|
2001-05-31 |
2011-06-15 |
Novartis Vaccines and Diagnostics, Inc. |
Chimäre Alphavirus-Replikonpartikel
|
US20070160576A1
(en)
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
KR100628425B1
(ko)
|
2001-06-20 |
2006-09-28 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
|
US7803915B2
(en)
|
2001-06-20 |
2010-09-28 |
Genentech, Inc. |
Antibody compositions for the diagnosis and treatment of tumor
|
ATE437222T1
(de)
*
|
2001-09-06 |
2009-08-15 |
Alphavax Inc |
Alphavirus replikon-vektorsysteme
|
NZ573831A
(en)
|
2001-09-18 |
2010-07-30 |
Genentech Inc |
Compositions and methods for the diagnosis and treatment of tumor, particularly breast tumor - TAT193
|
AR045702A1
(es)
|
2001-10-03 |
2005-11-09 |
Chiron Corp |
Composiciones de adyuvantes.
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
MXPA04006554A
(es)
|
2002-01-02 |
2005-03-31 |
Genentech Inc |
Composiciones y metodos para diagnostico y tratamiento de tumor.
|
US7501134B2
(en)
|
2002-02-20 |
2009-03-10 |
Novartis Vaccines And Diagnostics, Inc. |
Microparticles with adsorbed polypeptide-containing molecules
|
US8802618B2
(en)
*
|
2002-03-08 |
2014-08-12 |
Board Of Regents, The University Of Texas System |
Controlled modulation of amino acid side chain length of peptide antigens
|
EP1571968A4
(de)
|
2002-04-16 |
2007-10-17 |
Genentech Inc |
Zusammensetzungen und verfahren zur diagnose und behandlung von tumoren
|
BR0308896A
(pt)
*
|
2002-05-07 |
2007-01-09 |
Chiron Corp |
complexos e hìbridos envelope do hiv-cd4
|
EP2305710A3
(de)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetische Antikörperphagenbibliotheken
|
JP4598518B2
(ja)
|
2002-06-19 |
2010-12-15 |
ユニバーシティー ヘルス ネットワーク |
心臓、肺および腎臓疾患および高血圧症の治療のためのace2活性化
|
CA2496925A1
(en)
*
|
2002-08-29 |
2004-03-11 |
Genentech, Inc. |
Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor
|
AU2003252591A1
(en)
|
2002-08-30 |
2004-03-29 |
Japan Science And Technology Corporation |
Method of targeted gene disruption, genome of hyperthermostable bacterium and genome chip using the same
|
US7179645B2
(en)
*
|
2002-09-24 |
2007-02-20 |
Antigen Express, Inc. |
Ii-Key/antigenic epitope hybrid peptide vaccines
|
CA2499123A1
(en)
|
2002-09-17 |
2004-04-15 |
Antigen Express, Inc. |
Ii-key/antigenic epitope hybrid peptide vaccines
|
ES2552687T3
(es)
*
|
2002-12-13 |
2015-12-01 |
Alphavax, Inc. |
Partículas alfavíricas y métodos de preparación
|
DK1585812T3
(en)
|
2002-12-13 |
2017-04-10 |
Alphavax Inc |
MULTI-ANTI-ANTI-ANTI-VIRUS REPLICATE PARTICLES AND PROCEDURES
|
EP1585542B1
(de)
|
2002-12-27 |
2012-06-13 |
Novartis Vaccines and Diagnostics, Inc. |
Immunogene zusammensetzungen enthaltend phospholipid
|
WO2004085660A2
(en)
*
|
2003-03-20 |
2004-10-07 |
Alphavax, Inc. |
Improved alphavirus replicons and helper constructs
|
CA2523875A1
(en)
*
|
2003-04-28 |
2004-11-11 |
Public Health Agency Of Canada |
Sars virus nucleotide and amino acid sequences and uses thereof
|
EP1628680B1
(de)
|
2003-05-15 |
2012-10-24 |
Novartis Vaccines and Diagnostics, Inc. |
Hiv polynucleotide und polypeptide von botswana mj4
|
ES2424353T3
(es)
|
2003-07-08 |
2013-10-01 |
Genentech, Inc. |
Polipéptidos heterólogos IL-17 A/F y usos terapéuticos de los mismos
|
AU2004257214B2
(en)
*
|
2003-07-11 |
2010-04-22 |
Alphavax, Inc. |
Alphavirus-based cytomegalovirus vaccines
|
US20060035242A1
(en)
|
2004-08-13 |
2006-02-16 |
Michelitsch Melissa D |
Prion-specific peptide reagents
|
CA2543763A1
(en)
*
|
2003-10-31 |
2005-05-12 |
The University Of British Columbia |
Bacterial virulence factors and uses thereof
|
PT1680141E
(pt)
|
2003-11-04 |
2010-12-20 |
Novartis Vaccines & Diagnostic |
Métodos terapêuticos para tumores sólidos que expressam o antigénio de superfície celular cd40
|
JP4746552B2
(ja)
|
2003-11-04 |
2011-08-10 |
ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド |
自己免疫疾患および炎症性疾患ならびに臓器移植拒絶の処置のためのアンタゴニスト抗cd40抗体の使用
|
US20070218060A1
(en)
|
2003-11-04 |
2007-09-20 |
Chiron Corporation |
Use of Antagonist Anti-Cd40 Monoclonal Antibodies for Treatment of Multiple Myeloma
|
EP1844815B1
(de)
|
2003-11-04 |
2011-09-14 |
Novartis Vaccines and Diagnostics, Inc. |
Kombinationstherapie von anti-CD20 und anti-CD40 Antikörpern zur Behandlung von B-Zell-bedingtem Krebs
|
DK1682177T3
(da)
|
2003-11-04 |
2010-11-01 |
Novartis Vaccines & Diagnostic |
Anvendelse af antagonist-anti-CD40-antistoffer til behandling af kronisk lymfocytisk leukæmi
|
JP4901478B2
(ja)
|
2003-11-17 |
2012-03-21 |
ジェネンテック, インコーポレイテッド |
造血系起源の腫瘍の治療のための組成物と方法
|
GB0330079D0
(en)
*
|
2003-12-20 |
2004-02-04 |
Bioinvent Int Ab |
Vaccine
|
WO2005107789A1
(en)
*
|
2004-04-30 |
2005-11-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Use of delta pkc peptides for modulation of reactive oxigen species
|
DE602005012382D1
(de)
|
2004-05-18 |
2009-03-05 |
Alphavax Inc |
Von tc-83 abgeleitete alphavirus-vektoren, partikel und verfahren
|
ES2647491T3
(es)
|
2004-05-21 |
2017-12-21 |
Novartis Vaccines And Diagnostics, Inc. |
Vectores del alfavirus para las vacunas del virus de la gripe
|
CA2569562C
(en)
*
|
2004-06-08 |
2013-12-03 |
Vega Masignani |
Fusion proteins comprising cd4 minimal modules and methods of use thereof
|
US7899623B2
(en)
|
2004-09-22 |
2011-03-01 |
Tripath Imaging, Inc. |
Methods and computer program products for analysis and optimization of marker candidates for cancer prognosis
|
EP2266602A3
(de)
|
2004-11-01 |
2011-08-10 |
Novartis Vaccines and Diagnostics, Inc. |
Kombinationswege zur Erzeugung von Immunantworten
|
AU2005313026B2
(en)
|
2004-12-06 |
2011-09-08 |
Kyowa Hakko Kirin Co., Ltd. |
Human monoclonal antibodies to influenza M2 protein and methods of making and using same
|
SG158155A1
(en)
*
|
2004-12-29 |
2010-01-29 |
Mannkind Corp |
Methods to bypass cd+4 cells in the induction of an immune response
|
CA2592500A1
(en)
*
|
2005-01-04 |
2006-07-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of increasing cerebral blood flow
|
WO2006084179A2
(en)
*
|
2005-02-03 |
2006-08-10 |
Novartis Vaccines And Diagnostics Inc. |
Hiv tat-cd4 hybried molecules and methods of use thereof
|
BRPI0607985A2
(pt)
|
2005-03-10 |
2009-10-27 |
Genentech Inc |
modulador da dscr1, métodos de tratamento, método de melhoria de efeitos colaterais e método de inibição do crescimento de tumores
|
US8834891B2
(en)
|
2005-03-14 |
2014-09-16 |
Boehringer Ingelheim Vetmedica, Inc. |
Immunogenic compositions comprising Lawsonia intracellularis
|
US7595380B2
(en)
|
2005-04-27 |
2009-09-29 |
Tripath Imaging, Inc. |
Monoclonal antibodies and methods for their use in the detection of cervical disease
|
GB0508726D0
(en)
*
|
2005-04-29 |
2005-06-08 |
Bioinvent Int Ab |
Polypeptide, vaccine and use thereof
|
DK1889065T3
(da)
|
2005-05-18 |
2013-09-02 |
Xoma Technology Ltd |
Metoder til diagnostisering og behandling af sygdomme med en autoimmun- og/eller inflammationskomponent
|
JP2008541781A
(ja)
|
2005-06-06 |
2008-11-27 |
ジェネンテック・インコーポレーテッド |
異なる遺伝子に対するトランスジェニック動物、および遺伝子の特徴づけのためのその使用
|
US7763460B2
(en)
|
2005-06-24 |
2010-07-27 |
Focus Diagnostics, Inc. |
Methods and compositions for detecting herpes simplex virus type 2
|
US8398994B2
(en)
|
2005-07-15 |
2013-03-19 |
Boehringer Ingelheim Vetmedica, Inc. |
Lawsonia vaccine and methods of use thereof
|
ZA200800970B
(en)
|
2005-08-15 |
2009-10-28 |
Genentech Inc |
Gene disruptions, compositions and methods relating thereto
|
US20080241184A1
(en)
|
2005-08-25 |
2008-10-02 |
Jules Maarten Minke |
Canine influenza vaccines
|
US8945573B2
(en)
|
2005-09-08 |
2015-02-03 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Targeted identification of immunogenic peptides
|
EP2357000A1
(de)
|
2005-10-18 |
2011-08-17 |
Novartis Vaccines and Diagnostics, Inc. |
Mukosale und systemische Immunisierungen mit Alphavirus-Replikonpartikeln
|
ZA200804162B
(en)
|
2005-11-21 |
2009-12-30 |
Genentech Inc |
Novel gene disruptions, compositions and methods relating thereto
|
ES2514316T3
(es)
|
2005-11-22 |
2014-10-28 |
Novartis Vaccines And Diagnostics, Inc. |
Partículas similares a virus (VLPs) de Norovirus y Sapovirus
|
TWI461436B
(zh)
|
2005-11-25 |
2014-11-21 |
Kyowa Hakko Kirin Co Ltd |
人類cd134(ox40)之人類單株抗體及其製造及使用方法
|
AU2006342792A1
(en)
|
2005-12-02 |
2007-11-08 |
Genentech, Inc. |
Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to IL-22 and IL-22R
|
US7632498B2
(en)
|
2005-12-19 |
2009-12-15 |
Tripath Imaging, Inc. |
MCM6 and MCM7 monoclonal antibodies and methods for their use in the detection of cervical disease
|
MY149398A
(en)
|
2005-12-29 |
2013-08-30 |
Boehringer Ingelheim Vetmed |
Multivalent pcv2 immunogenic compositions and methods of producing such compositions
|
MX2008008311A
(es)
|
2005-12-29 |
2009-03-04 |
Boehringer Ingelheim Vetmed |
Uso de una composicion inmunogenica de pcv2 para reducir los sintomas clinicos en cerdos.
|
EP2363711A1
(de)
|
2006-01-27 |
2011-09-07 |
Tripath Imaging, Inc. |
Verfahren zur Identifizierung von Patienten mit erhöhter Wahrscheinlichkeit des Auftretens eines Ovarialkarzinoms und Zusammensetzungen dafür
|
ZA200807714B
(en)
|
2006-02-17 |
2010-01-27 |
Genentech Inc |
Gene disruptions, compositions and methods relating thereto
|
JP2009531464A
(ja)
|
2006-03-29 |
2009-09-03 |
メリアル リミテッド |
連鎖球菌に対するワクチン
|
WO2007126455A2
(en)
|
2006-04-05 |
2007-11-08 |
Genentech, Inc. |
Method for using boc/cdo to modulate hedgehog signaling
|
CA2649387A1
(en)
|
2006-04-19 |
2008-03-27 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
GEP20125628B
(en)
|
2006-04-21 |
2012-09-10 |
Novartis Ag |
Pharmaceutical compositions containing antagonist anti-cd40 antibody
|
US20090142259A1
(en)
*
|
2006-05-12 |
2009-06-04 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors
|
CA2660286A1
(en)
|
2006-08-09 |
2008-02-21 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
JP2010503407A
(ja)
|
2006-09-12 |
2010-02-04 |
ジェネンテック・インコーポレーテッド |
癌の診断及び治療のための方法及び組成物
|
US8865183B2
(en)
|
2006-12-15 |
2014-10-21 |
Boehringer Ingelheim Vetmedica, Inc. |
Treatment of pigs with PCV2 antigent
|
EP1941903A1
(de)
|
2007-01-03 |
2008-07-09 |
Boehringer Ingelheim Vetmedica Gmbh |
Prophylaxe und Behandlung von PRDC
|
EP1958644A1
(de)
|
2007-02-13 |
2008-08-20 |
Boehringer Ingelheim Vetmedica Gmbh |
Vorbeugung und Behandlung von subklinischer PCVD
|
MX2009008736A
(es)
|
2007-02-22 |
2009-08-24 |
Genentech Inc |
Metodos para detectar la enfermedad inflamatoria intestinal.
|
EP2146743A2
(de)
|
2007-04-12 |
2010-01-27 |
Stichting Katholieke Universiteit, more particularly the Radboud University Nijmegen Medical Centre |
Neue virulenz-faktoren von streptococcus pneumoniae
|
US20100210708A1
(en)
*
|
2007-04-13 |
2010-08-19 |
Cytopathfinder, Inc. |
Compound profiling method
|
AU2008266807B2
(en)
*
|
2007-06-21 |
2012-08-16 |
Alphavax, Inc. |
Promoterless cassettes for expression of alphavirus structural proteins
|
US20090017064A1
(en)
*
|
2007-07-10 |
2009-01-15 |
Wyeth |
Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
|
AU2008307145B2
(en)
*
|
2007-10-04 |
2014-07-10 |
Bionomics Limited |
Markers of endothelial cells and uses thereof
|
PE20091163A1
(es)
|
2007-11-01 |
2009-08-09 |
Wyeth Corp |
Anticuerpos para gdf8
|
DK2514436T3
(en)
|
2007-11-07 |
2018-03-12 |
Genentech Inc |
IL-22 FOR USE IN TREATMENT OF MICROBIAL DISEASES
|
WO2009064944A2
(en)
|
2007-11-16 |
2009-05-22 |
Nuvelo, Inc. |
Antibodies to lrp6
|
KR20100094587A
(ko)
*
|
2007-12-21 |
2010-08-26 |
와이어쓰 엘엘씨 |
돼지 써코바이러스에 대해 돼지를 면역시키는 방법 및 조성물
|
EP2077119A1
(de)
*
|
2007-12-21 |
2009-07-08 |
Apeiron Biologics Forschungs- und Entwicklungsgesellschaft M.B.H. |
Behandlung von Fibrosen und Lebererkrankungen
|
US20090175906A1
(en)
*
|
2007-12-21 |
2009-07-09 |
Wyeth |
Genetically Modified Attenuated Vesicular Stomatitis Virus, Compositions and Methods of use Thereof
|
NZ589795A
(en)
|
2008-06-16 |
2013-02-22 |
Patrys Ltd |
Use of LM-1 antibody which binds to NONO/nmt55 protein to prevent metastasis
|
US9182406B2
(en)
|
2008-08-04 |
2015-11-10 |
Biodesy, Inc. |
Nonlinear optical detection of molecules comprising an unnatural amino acid possessing a hyperpolarizability
|
EP2174664A1
(de)
|
2008-10-07 |
2010-04-14 |
Stichting Katholieke Universiteit, more particularly the Radboud University Nijmegen Medical Centre |
Neue Virulenzfaktoren von Pneumokokken
|
MX2011005604A
(es)
|
2008-11-28 |
2011-09-01 |
Merial Ltd |
Vacuna recombinante para influenza aviar y sus usos.
|
BRPI0923199B8
(pt)
|
2008-12-01 |
2021-07-27 |
Univ Leland Stanford Junior |
método para determinar a presença de anticorpos de fixação de complemento
|
EP2376535B9
(de)
|
2008-12-09 |
2017-09-13 |
F. Hoffmann-La Roche AG |
Anti-pd-l1-antikörper und deren verwendung zur verbesserung der t-zellen-funktion
|
CA2750922A1
(en)
*
|
2009-01-28 |
2010-08-05 |
Antigen Express, Inc. |
Li-key hybrid peptides that modulate the immune response to influenza
|
EP2403880A1
(de)
|
2009-03-05 |
2012-01-11 |
Tripath Imaging, Inc. |
Monoklonale antikörper gegen matrixmetalloproteinase-7 (mmp-7) und verfahren zu ihrer verwendung beim nachweis von eierstockkrebs
|
JP2012524521A
(ja)
|
2009-03-06 |
2012-10-18 |
トライパス イメージング インコーポレイテッド |
グリコデリンモノクローナル抗体および卵巣癌の検出におけるその使用のための方法
|
CN102428099B
(zh)
|
2009-04-03 |
2016-03-16 |
梅里亚有限公司 |
运载新城疫病毒的禽疫苗
|
HUE036372T2
(hu)
|
2009-06-22 |
2018-07-30 |
Wyeth Llc |
Staphylococcus aureus antigének immunogén készítményei
|
CA2766418C
(en)
|
2009-06-22 |
2016-03-29 |
Wyeth Llc |
Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
|
MX2012002114A
(es)
|
2009-08-21 |
2012-08-08 |
Univ Georgia |
Vacuna de paramixovirus aviar recombinante y metodo para hacerla y usarla.
|
CN102597775A
(zh)
|
2009-09-25 |
2012-07-18 |
佐马技术有限公司 |
筛选方法
|
US8926976B2
(en)
|
2009-09-25 |
2015-01-06 |
Xoma Technology Ltd. |
Modulators
|
ES2564207T3
(es)
|
2009-10-22 |
2016-03-18 |
F. Hoffmann-La Roche Ag |
Métodos y composiciones para modular la activación con hepsina de la proteína estimuladora de macrófagos
|
EP2501414B1
(de)
|
2009-11-17 |
2018-01-10 |
The Trustees Of The University Of Pennsylvania |
Smn-delta-7-degron: neuartige zusammensetzungen und verfahren zu ihrer verwendung
|
EP2507264A2
(de)
|
2009-11-30 |
2012-10-10 |
F. Hoffmann-La Roche AG |
Antikörper zur behandlung und diagnostizierung von slc34a2-exprimierenden tumoren (tat211 = seqid 2)
|
WO2011075379A1
(en)
|
2009-12-18 |
2011-06-23 |
Boehringer Ingelheim Vetmedica, Inc. |
Multivalent vaccine against porcine teschovirus and other disease causing organisms in swine
|
MX351643B
(es)
|
2009-12-28 |
2017-10-23 |
Merial Ltd |
Antigeno ndv recombinante y usos del mismo.
|
RU2587619C2
(ru)
|
2010-02-18 |
2016-06-20 |
Дженентек, Инк. |
Антагонисты неурегулина и применение их в лечении злокачественного новообразования
|
US8877897B2
(en)
|
2010-02-23 |
2014-11-04 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
US20130197612A1
(en)
|
2010-02-26 |
2013-08-01 |
Jack W. Lasersohn |
Electromagnetic Radiation Therapy
|
EP2544715A2
(de)
|
2010-03-09 |
2013-01-16 |
Board Of Regents, University Of Texas System |
Verfahren und zusammensetzung für chlamydia-antigen zur diagnose und behandlung einer chlamydieninfektion und -erkranung
|
MA34087B1
(fr)
|
2010-03-12 |
2013-03-05 |
Merial Ltd |
Vaccins recombinants contre le virus de la langue bleue et leurs utilisations
|
WO2011139985A1
(en)
|
2010-05-03 |
2011-11-10 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
MX2012012927A
(es)
|
2010-05-06 |
2013-05-01 |
Novartis Ag |
Composiciones y metodos de uso para anticuerpos multivalentes terapeuticos de proteina relacionada con lipoproteina de baja densidad 6 (lrp6).
|
EA201291180A1
(ru)
|
2010-05-06 |
2013-05-30 |
Новартис Аг |
Композиции и способы применения терапевтических антител против белка, родственного рецептору липопротеинов низкой плотности 6 (lrp6)
|
EP2575988A1
(de)
|
2010-05-28 |
2013-04-10 |
Tetris Online, Inc. |
Interaktive, hybride und asynchrone computerspiel-infrastruktur
|
US9192661B2
(en)
|
2010-07-06 |
2015-11-24 |
Novartis Ag |
Delivery of self-replicating RNA using biodegradable polymer particles
|
KR102027011B1
(ko)
|
2010-08-20 |
2019-09-30 |
노파르티스 아게 |
표피 성장 인자 수용체 3 (her3)에 대한 항체
|
PL3246044T3
(pl)
|
2010-08-23 |
2021-08-23 |
Wyeth Llc |
Stabilne preparaty antygenów rLP2086 Neisseria meningitidis
|
EP2611460B1
(de)
|
2010-08-31 |
2016-10-05 |
Merial, Inc. |
Auf das virus der newcastle-krankheit gerichtete herpesvirus-impfstoffe
|
CA2809758C
(en)
|
2010-09-10 |
2021-07-13 |
Wyeth Llc |
Non-lipidated variants of neisseria meningitidis orf2086 antigens
|
WO2012071436A1
(en)
|
2010-11-24 |
2012-05-31 |
Genentech, Inc. |
Method of treating autoimmune inflammatory disorders using il-23r loss-of-function mutants
|
EP2643353A1
(de)
|
2010-11-24 |
2013-10-02 |
Novartis AG |
Multispezifische moleküle
|
WO2012075111A1
(en)
|
2010-11-30 |
2012-06-07 |
Novartis Ag |
Uses of anti-cd40 antibodies in combination therapy for b cell-related cancers
|
DK2654784T3
(en)
|
2010-12-22 |
2017-02-13 |
Wyeth Llc |
STABLE IMMUNOGENIC COMPOSITIONS OF STAPHYLOCOCCUS AUREUS ANTIGENES
|
CA2826229A1
(en)
|
2011-02-11 |
2012-08-16 |
Pioneer Hi-Bred International, Inc. |
Synthetic insecticidal proteins active against corn rootworm
|
US9428789B2
(en)
|
2011-03-21 |
2016-08-30 |
Biodesy, Inc. |
Classification of kinase inhibitors using nonlinear optical techniques
|
WO2012142526A1
(en)
|
2011-04-14 |
2012-10-18 |
Modiano Jaime |
Use of tumor fas expression to determine response to anti-cancer therapy
|
WO2012144546A1
(ja)
*
|
2011-04-22 |
2012-10-26 |
ロート製薬株式会社 |
新規ペプチド
|
CN103945864A
(zh)
|
2011-04-25 |
2014-07-23 |
先进生物学实验室股份有限公司 |
截短的hiv包膜蛋白(env)、其相关方法和组合物
|
EP2714722B1
(de)
|
2011-05-27 |
2019-09-11 |
Boehringer Ingelheim Animal Health USA Inc. |
Genetischer impfstoff gegen hendra- und nipah-virus
|
TW201840336A
(zh)
|
2011-08-01 |
2018-11-16 |
美商建南德克公司 |
利用pd-1軸結合拮抗劑及mek抑制劑治療癌症之方法
|
WO2013024517A1
(ja)
|
2011-08-12 |
2013-02-21 |
国立感染症研究所 |
アスペルギルス フミガーツス感染症の検査、予防及び治療のための方法並びに組成物
|
HUE058855T2
(hu)
|
2011-08-16 |
2022-09-28 |
Morphosys Ag |
Kombinációs terápia, CD19 elleni ellenanyag és purinanalóg alkalmazásával
|
KR20200058583A
(ko)
|
2011-08-16 |
2020-05-27 |
모르포시스 아게 |
항-cd19 항체 및 질소 머스타드를 사용한 조합 요법
|
WO2013033092A2
(en)
|
2011-09-03 |
2013-03-07 |
Boehringer Ingelheim Vetmedica Gmbh |
Streptococcus suis pilus antigens
|
KR20140068062A
(ko)
|
2011-09-15 |
2014-06-05 |
제넨테크, 인크. |
분화의 촉진 방법
|
JP6254087B2
(ja)
|
2011-10-15 |
2017-12-27 |
ジェネンテック, インコーポレイテッド |
癌を治療するためのscd1アンタゴニスト
|
ES2666856T3
(es)
|
2011-11-04 |
2018-05-08 |
Novartis Ag |
Proteína 6 relacionada con lipoproteínas de baja densidad (LRP6) - constructos extensores de la vida media
|
MX361893B
(es)
|
2011-11-30 |
2018-12-18 |
Merial Inc |
Vectores recombinantes de herpesvirus 3 galido (mdv serotipo 2) que expresan antigenos de patogenos de aves y sus usos.
|
EP3590538A1
(de)
|
2011-12-05 |
2020-01-08 |
Novartis AG |
Antikörper für den epidermalen wachstumsfaktorrezeptor 3 (her 3)
|
BR112014013568A8
(pt)
|
2011-12-05 |
2017-06-13 |
Novartis Ag |
anticorpos para o receptor do fator de crescimento epidermal 3 (her3) direcionados para o domínio ii do her3
|
WO2013093629A2
(en)
|
2011-12-20 |
2013-06-27 |
Netherlands Cancer Institute |
Modular vaccines, methods and compositions related thereto
|
WO2013094720A1
(ja)
*
|
2011-12-22 |
2013-06-27 |
ロート製薬株式会社 |
細胞接着促進能を有する組成物
|
EP2804630B1
(de)
|
2012-01-18 |
2017-10-18 |
F. Hoffmann-La Roche AG |
Verfahren zur verwendung von fgf19-modulatoren
|
WO2013162654A1
(en)
|
2012-04-25 |
2013-10-31 |
Biodesy, Llc |
Methods for detecting allosteric modulators of proteins
|
JP6545959B2
(ja)
|
2012-02-11 |
2019-07-17 |
ジェネンテック, インコーポレイテッド |
Rスポンジン転位およびその使用方法
|
MX360415B
(es)
|
2012-02-14 |
2018-10-31 |
Merial Inc |
Vectores poxvirales recombinantes que expresan proteinas tanto de rabia como de ox40, y vacunas hechas a partir de los mismos.
|
US9446117B2
(en)
|
2012-02-14 |
2016-09-20 |
Merial, Inc. |
Rotavirus subunit vaccines and methods of making and use thereof
|
WO2013129456A1
(ja)
*
|
2012-02-29 |
2013-09-06 |
ロート製薬株式会社 |
線維芽細胞増殖促進能を有する組成物
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
CN104334187B
(zh)
|
2012-03-09 |
2017-04-05 |
辉瑞公司 |
脑膜炎双球菌组合物及其方法
|
US9139863B2
(en)
|
2012-03-16 |
2015-09-22 |
Genentech, Inc. |
Engineered conformationally-stabilized proteins
|
JP2015511598A
(ja)
|
2012-03-16 |
2015-04-20 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
Pak1阻害剤を用いて黒色腫を治療する方法
|
WO2013137920A1
(en)
|
2012-03-16 |
2013-09-19 |
Genentech, Inc. |
Engineered conformationally-stabilized proteins
|
BR112014024612A2
(pt)
|
2012-04-02 |
2021-06-08 |
Univ North Carolina Chapel Hill |
ácido nucleico, polipeptídeo, glicoproteína e quimérica, epítopo de vírus da dengue, partícula semelhante a flavivírus quimérico (vlp), flavivírus quimérico, e métodos in vitro para identificar um anticorpo neutralizante e para identificar uma composição imunogênica contra um vírus da dengue
|
US9597386B2
(en)
|
2012-04-05 |
2017-03-21 |
Boehringer Ingelheim Vetmedica, Inc. |
Outer membrane proteins of Histophilus somni and methods thereof
|
CN104470950B
(zh)
|
2012-05-11 |
2017-04-26 |
公益财团法人微生物化学研究会 |
抗cxadr抗体
|
WO2013170191A1
(en)
|
2012-05-11 |
2013-11-14 |
Genentech, Inc. |
Methods of using antagonists of nad biosynthesis from nicotinamide
|
KR102129636B1
(ko)
|
2012-05-31 |
2020-07-03 |
제넨테크, 인크. |
Pd-l1 축 결합 길항제 및 vegf 길항제를 사용하여 암을 치료하는 방법
|
CN104582724A
(zh)
|
2012-06-13 |
2015-04-29 |
梅里亚有限公司 |
重配btv和ahsv疫苗
|
NZ703701A
(en)
|
2012-06-27 |
2016-03-31 |
Merial Inc |
Attenuated streptococcus suis vaccines and methods of making and use thereof
|
JP6519851B2
(ja)
|
2012-07-06 |
2019-05-29 |
京都府公立大学法人 |
眼細胞の分化マーカーおよび分化制御
|
BR112015001020B1
(pt)
|
2012-07-17 |
2022-04-19 |
Merial, Inc. |
Vacinas de influenza suína atenuada e métodos de produção e utilização das mesmas
|
AU2013303826B2
(en)
|
2012-08-16 |
2017-06-29 |
Pfizer Inc. |
Glycoconjugation processes and compositions
|
EA031988B1
(ru)
|
2012-08-30 |
2019-03-29 |
Мериал, Инк. |
Гипербарическое устройство и способы получения инактивированных вакцин и повторно свернутых/солюбилизированных рекомбинантных белков
|
US9555098B2
(en)
|
2012-09-10 |
2017-01-31 |
Merial Inc. |
Attenuated parvovirus vaccine for Muscovy duck parvovirus and goose parvovirus (Derzsys disease)
|
EP2916863B1
(de)
|
2012-11-08 |
2018-05-30 |
Merial, Inc. |
Attenuierte mannheimia-haemolytica-impfstoffe sowie verfahren zur herstellung und verwendung
|
US20140170180A1
(en)
|
2012-12-17 |
2014-06-19 |
Boehringer Ingelheim Vetmedica, Inc. |
Porcine parvovirus 5a, methods of use and vaccine
|
KR20150110531A
(ko)
|
2012-12-18 |
2015-10-02 |
메리얼 인코포레이티드 |
Ibv, csfv 및 ndv 의 고 해상도 용융 유전자형분석
|
EP4169929A1
(de)
|
2012-12-20 |
2023-04-26 |
Pfizer Inc. |
Immunogene zusammensetzungen mit pn-serotype 12f
|
BR112015018330A2
(pt)
|
2013-02-01 |
2017-07-18 |
Univ Auburn |
cepas de flavobacterium vivas modificadas, vacinas estabilizadas compreendendo as mesmas, e métodos de preparo e uso das mesmas
|
US20140234354A1
(en)
|
2013-02-15 |
2014-08-21 |
Boehringer Ingelheim Vetmedica, Inc. |
Porcine parvovirus 5b, methods of use and vaccine
|
BR112015018418A2
(pt)
|
2013-02-22 |
2017-07-18 |
Hoffmann La Roche |
métodos para tratar câncer, para aumentar a eficácia de um tratamento, para adiar e/ou prevenir o desenvolvimento de câncer, para aumentar a sensibilidade a um terapêutico direcionado, para estender o período de sensibilidade, para estender a duração de resposta a um terapêutico direcionado e produto farmacêutico
|
US9925240B2
(en)
|
2013-03-06 |
2018-03-27 |
Genentech, Inc. |
Methods of treating and preventing cancer drug resistance
|
JP6446377B2
(ja)
|
2013-03-08 |
2018-12-26 |
ファイザー・インク |
免疫原性融合ポリペプチド
|
BR112015022844B1
(pt)
|
2013-03-14 |
2023-01-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Método para determinar a presença ou ausência de anticorpos específicos do doador em uma amostra biológica, sistema e kit para praticar o mesmo
|
RU2015139054A
(ru)
|
2013-03-14 |
2017-04-19 |
Дженентек, Инк. |
Способы лечения рака и профилактики лекарственной резистентности рака
|
EP2970479B1
(de)
|
2013-03-14 |
2019-04-24 |
Novartis AG |
Antikörper gegen notch 3
|
JP6456356B2
(ja)
|
2013-03-15 |
2019-01-23 |
ジェネンテック, インコーポレイテッド |
IL−22ポリペプチド及びIL−22Fc融合タンパク質並びに使用方法
|
EP2968513A2
(de)
|
2013-03-15 |
2016-01-20 |
Boehringer Ingelheim Vetmedica, Inc. |
Prrs-virus, zusammensetzungen, impfstoff und verfahren zur verwendung
|
WO2014144850A1
(en)
|
2013-03-15 |
2014-09-18 |
Genentech, Inc. |
Methods of treating cancer and preventing cancer drug resistance
|
EP3633377A1
(de)
|
2013-03-15 |
2020-04-08 |
F. Hoffmann-La Roche AG |
Biomarker und verfahren zur behandlung von pd-1 und pd-l1-verwandten leiden
|
CA2918644A1
(en)
|
2013-06-26 |
2014-12-31 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for dengue virus vaccines
|
RU2019129525A
(ru)
|
2013-07-16 |
2019-11-05 |
Дженентек, Инк. |
Способы лечения рака с использованием антагонистов, связывающих с осью pd-1, и ингибиторов tigit
|
CN105492021B
(zh)
|
2013-09-08 |
2018-12-04 |
辉瑞公司 |
脑膜炎奈瑟氏球菌组合物及其方法
|
JP6821429B2
(ja)
|
2013-09-25 |
2021-01-27 |
ゾエティス・サービシーズ・エルエルシー |
Pcv2b分岐ワクチン組成物及び使用方法
|
EP3062816B1
(de)
|
2013-11-01 |
2020-08-05 |
Boehringer Ingelheim Animal Health USA Inc. |
Attenuierte pasteurella-multocida-impfstoffe und verfahren zur herstellung und verwendung davon
|
WO2015095410A1
(en)
|
2013-12-17 |
2015-06-25 |
Genentech, Inc. |
Methods of treating cancer using pd-1 axis binding antagonists and an anti-cd20 antibody
|
WO2015116902A1
(en)
|
2014-01-31 |
2015-08-06 |
Genentech, Inc. |
G-protein coupled receptors in hedgehog signaling
|
JP2017505792A
(ja)
|
2014-02-14 |
2017-02-23 |
ファイザー・インク |
免疫原性糖タンパク質コンジュゲート
|
KR101924271B1
(ko)
|
2014-03-25 |
2019-02-22 |
메리얼 인코포레이티드 |
약독화된 히스토필러스 솜니를 함유하는 면역학적 조성물
|
CN106456784A
(zh)
|
2014-04-16 |
2017-02-22 |
拜康有限公司 |
包含摩尔过量的山梨醇的稳定蛋白质制剂
|
WO2015171523A1
(en)
|
2014-05-05 |
2015-11-12 |
Regeneron Pharmaceuticals, Inc. |
Humanized c5 and c3 animals
|
JP2017524371A
(ja)
|
2014-05-23 |
2017-08-31 |
ジェネンテック, インコーポレイテッド |
Mitバイオマーカーとその使用方法
|
WO2015191986A1
(en)
|
2014-06-13 |
2015-12-17 |
Genentech, Inc. |
Methods of treating and preventing cancer drug resistance
|
MX2017000546A
(es)
|
2014-07-15 |
2017-03-08 |
Genentech Inc |
Composiciones para el tratamiento del cancer mediante el uso de antagonistas de union al eje de pd-1 e inhibidores de mek.
|
WO2016011167A1
(en)
|
2014-07-16 |
2016-01-21 |
Dana-Farber Cancer Institute, Inc., Et Al |
Her3 inhibition in low-grade serous ovarian cancers
|
EP3188746B1
(de)
|
2014-09-05 |
2024-06-19 |
The Johns Hopkins University |
Capn9-aktivität als ziel für eine therapeutische strategie zur behandlung von myofibroblastendifferenzierung und assoziierten erkrankungen
|
WO2016038550A1
(en)
|
2014-09-11 |
2016-03-17 |
Novartis Ag |
Inhibition of prmt5 to treat mtap-deficiency-related diseases
|
KR20170075775A
(ko)
|
2014-11-02 |
2017-07-03 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
백신 및 진단제 개발을 위한 재조합 뎅기 바이러스에 대한 방법 및 조성물
|
BR112017010324A2
(pt)
|
2014-11-20 |
2018-05-15 |
F. Hoffmann-La Roche Ag |
método para tratar ou retardar a progressão de um câncer em um indivíduo, moléculas, métodos para aumentar a função imune em um indivíduo e para selecionar um paciente para tratamento, kits, composição farmacêutica e usos de uma combinação de uma molécula
|
EP3227446A1
(de)
|
2014-12-01 |
2017-10-11 |
Novartis AG |
Zusammensetzungen und verfahren zur diagnose und behandlung von prostatakrebs
|
US20160158360A1
(en)
|
2014-12-05 |
2016-06-09 |
Genentech, Inc. |
Methods and compositions for treating cancer using pd-1 axis antagonists and hpk1 antagonists
|
US10996222B2
(en)
|
2014-12-05 |
2021-05-04 |
Boehringer Ingelheim Animal Health USA Inc. |
Enzyme-linked immunosorbent assay (ELISA) for the detection of anti-mycoplasma hyorhinis IgG in swine serum
|
UY36449A
(es)
|
2014-12-19 |
2016-07-29 |
Novartis Ag |
Composiciones y métodos para anticuerpos dirigidos a bmp6
|
WO2016106286A1
(en)
|
2014-12-23 |
2016-06-30 |
Biodesy, Inc. |
Attachment of proteins to interfaces for use in nonlinear optical detection
|
WO2016132294A1
(en)
|
2015-02-19 |
2016-08-25 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
DK3258960T3
(da)
|
2015-02-20 |
2021-04-19 |
Boehringer Ingelheim Animal Health Usa Inc |
Leptospira-immunbeskyttende proteiner og fremgangsmåder til identifikation og anvendelse deraf
|
US10596247B2
(en)
|
2015-02-20 |
2020-03-24 |
Board Of Regents, The University Of Texas System |
Methods and compositions for attenuated chlamydia as vaccine and vector
|
US10376535B2
(en)
|
2015-03-26 |
2019-08-13 |
University Of Rochester |
Therapy for malignant disease
|
CA3155251A1
(en)
|
2015-05-01 |
2016-11-10 |
The Regents Of The University Of California |
Glycan-dependent immunotherapeutic molecules
|
EP3292146A1
(de)
|
2015-05-04 |
2018-03-14 |
Pfizer Inc |
Gruppe-b-streptococcus-polysaccharid-proteinkonjugate, verfahren zur herstellung von konjugaten, immunogene zusammensetzungen mit konjugaten und verwendungen davon
|
PT3297666T
(pt)
|
2015-05-22 |
2019-09-06 |
Consejo Superior Investigacion |
Adjuvante e vacina molecular
|
CA3025145A1
(en)
|
2015-05-22 |
2016-12-01 |
Translational Drug Development Llc |
Benzamide and active compound compositions and methods of use
|
EP3603672A1
(de)
|
2015-05-26 |
2020-02-05 |
MorphoSys AG |
Kombination aus einem anti-cd19-antikörper und einem bruton-tyrosinkinase-inhibitor und verwendungen davon
|
WO2016191389A2
(en)
|
2015-05-27 |
2016-12-01 |
Merial, Inc. |
Compositions containing antimicrobial igy antibodies, for treatment and prevention of disorders and diseases caused by oral health compromising (ohc) microorganisms
|
US20180296537A1
(en)
|
2015-06-05 |
2018-10-18 |
Novartis Ag |
Methods and compositions for diagnosing, treating, and monitoring treatment of shank3 deficiency associated disorders
|
BR112017021484A2
(pt)
|
2015-06-05 |
2018-07-03 |
Novartis Ag |
anticorpos de direcionamento à proteína morfogenética óssea 9 (bmp9) e métodos para os mesmos
|
EP3311165B1
(de)
|
2015-06-19 |
2020-12-09 |
University Of Rochester |
Septinproteine als neuartige biomarker zur detektion und behandlung von müllerschen tumoren
|
AR105482A1
(es)
|
2015-06-23 |
2017-10-11 |
Merial Inc |
Vectores virales recombinantes que contienen la proteína menor del virus del síndrome reproductor y respiratorio porcino (prrsv) y sus métodos de elaboración y uso
|
CA2996143A1
(en)
|
2015-08-20 |
2017-02-23 |
Merial, Inc. |
Fcv recombinant vaccines and uses thereof
|
RS62260B1
(sr)
|
2015-08-21 |
2021-09-30 |
Morphosys Ag |
Kombinacije i njihova upotreba
|
CN108135993B
(zh)
|
2015-08-31 |
2022-03-22 |
贝林格尔·英格海姆维特梅迪卡有限公司 |
用于先天性震颤的瘟病毒疫苗
|
UY36889A
(es)
|
2015-09-09 |
2017-04-28 |
Novartis Ag |
Moléculas de unión a linfopoyetina estromal timica (tslp) y métodos de uso de las moléculas
|
EP3842457A1
(de)
|
2015-09-09 |
2021-06-30 |
Novartis AG |
Moleküle zur bindung von thymus-stroma-lymphopoietin (tslp) und verfahren zur verwendung der moleküle
|
SI3355915T1
(sl)
|
2015-09-29 |
2024-03-29 |
Boehringer Ingelheim Animal Health USA Inc. |
Cepiva z virusu podobnim delcem (vlp) pasjega parvovirusa (cpv) in njihove uporabe
|
JP2018529719A
(ja)
|
2015-09-30 |
2018-10-11 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
Alk陰性がんを処置するためのpd−1系結合アンタゴニストおよびalk阻害剤の組合せ
|
US11273151B2
(en)
|
2015-11-04 |
2022-03-15 |
Icahn School Of Medicine At Mount Sinai |
Methods of treating tumors and cancer, and identifying candidate subjects for such treatment
|
US10527613B2
(en)
|
2015-11-10 |
2020-01-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Biomarker detection methods and systems and kits for practicing same
|
JP2019500025A
(ja)
|
2015-11-18 |
2019-01-10 |
オービス ヘルス ソリューションズ エルエルシー |
T7アルファウイルスベクター系
|
MA42640B1
(fr)
|
2015-11-23 |
2021-06-30 |
Merial Inc |
Protéines de fusion de dmdv et e2 et leurs utilisations
|
US10188725B2
(en)
|
2015-12-14 |
2019-01-29 |
Elanco Us Inc. |
Hybrid core feline vaccines
|
WO2017103895A1
(en)
|
2015-12-18 |
2017-06-22 |
Novartis Ag |
Antibodies targeting cd32b and methods of use thereof
|
EP3405587A4
(de)
|
2015-12-23 |
2019-10-30 |
Moonshot Pharma LLC |
Verfahren zur auslösung einer immunreaktion durch read-through-förderung eines vorzeitigen terminationscodons
|
CA3009001A1
(en)
|
2016-01-11 |
2017-07-20 |
Universitat Zurich |
Immune-stimulating humanized monoclonal antibodies against human interleukin-2, and fusion proteins thereof
|
US20210198368A1
(en)
|
2016-01-21 |
2021-07-01 |
Novartis Ag |
Multispecific molecules targeting cll-1
|
TWI760322B
(zh)
|
2016-01-29 |
2022-04-11 |
美商百靈佳殷格翰動物保健美國有限公司 |
重組腺病毒載體裝載之fmdv疫苗及其用途
|
EA037813B1
(ru)
|
2016-02-19 |
2021-05-24 |
МорфоСис АГ |
Антитела к il-17c
|
AU2017244108B2
(en)
|
2016-03-29 |
2021-03-18 |
University Of Southern California |
Chimeric antigen receptors targeting cancer
|
MA44624A
(fr)
|
2016-04-07 |
2019-02-13 |
Merial Inc |
Vaccin contre le ver du c ur, procédés et utilisations associés
|
US11246868B2
(en)
|
2016-04-26 |
2022-02-15 |
Icahn School Of Medicine At Mount Sinai |
Treatment of hippo pathway mutant tumors and methods of identifying subjects as candidates for treatment
|
AU2017283787B2
(en)
|
2016-06-15 |
2020-09-17 |
Novartis Ag |
Methods for treating disease using inhibitors of bone morphogenetic protein 6 (BMP6)
|
RU2748024C2
(ru)
|
2016-06-27 |
2021-05-19 |
МорфоСис АГ |
Составы на основе антитела к CD19
|
AU2017292646A1
(en)
|
2016-07-05 |
2019-02-07 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
US11795202B2
(en)
|
2016-08-04 |
2023-10-24 |
Stichting Vumc |
Fusion polypeptide comprising a foreign antigen and self antigen
|
CA3153265A1
(en)
|
2016-08-17 |
2018-02-22 |
Pharmaq As |
Sea lice vaccine
|
AR109539A1
(es)
|
2016-09-20 |
2018-12-19 |
Boehringer Ingelheim Vetmedica Gmbh |
Sitio de inserción orf70 de ehv
|
AU2017329672B2
(en)
|
2016-09-20 |
2023-07-27 |
Boehringer Ingelheim Vetmedica Gmbh |
New promoters
|
AR109538A1
(es)
|
2016-09-20 |
2018-12-19 |
Boehringer Ingelheim Vetmedica Gmbh |
Vacuna contra la gripe porcina
|
AU2017332677B2
(en)
|
2016-09-20 |
2024-01-11 |
Boehringer Ingelheim Vetmedica Gmbh |
Canine adenovirus vectors
|
PE20191153A1
(es)
|
2016-09-28 |
2019-09-05 |
Blade Therapeutics Inc |
Moduladores de calpainas y usos terapeuticos de los mismos
|
PT3532098T
(pt)
|
2016-10-28 |
2021-06-17 |
Morphosys Ag |
Combinação de anticorpo anti cd19 com um inibidor bcl-2 e suas utilizações
|
EP3535396A1
(de)
|
2016-11-01 |
2019-09-11 |
Novartis AG |
Verfahren und zusammensetzungen zur verbesserung der genbearbeitung
|
US10751402B2
(en)
|
2016-11-09 |
2020-08-25 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|
JP2020500020A
(ja)
|
2016-11-14 |
2020-01-09 |
ノバルティス アーゲー |
融合誘導性タンパク質minionに関連する組成物、方法、および治療上の使用
|
AU2017363337B2
(en)
|
2016-11-23 |
2021-07-01 |
Translational Drug Development, Llc |
Benzamide and active compound compositions and methods of use
|
KR20190099218A
(ko)
|
2016-11-30 |
2019-08-26 |
뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 |
약독화된 돼지 인플루엔자 백신 및 이의 제조 및 사용 방법
|
IL303108B1
(en)
|
2017-01-31 |
2024-03-01 |
Pfizer |
NEISSERIA MENINGITIDIS preparations and methods therefor
|
WO2018152496A1
(en)
|
2017-02-17 |
2018-08-23 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Compositions and methods for the diagnosis and treatment of zika virus infection
|
JP7169979B2
(ja)
|
2017-02-27 |
2022-11-11 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
補体関連腎症および肝線維症の候補治療剤の治療有効性を評価する方法
|
AU2018254586A1
(en)
|
2017-04-21 |
2019-10-17 |
Genentech, Inc. |
Use of KLK5 antagonists for treatment of a disease
|
US11236151B2
(en)
|
2017-04-25 |
2022-02-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection
|
WO2018229715A1
(en)
|
2017-06-16 |
2018-12-20 |
Novartis Ag |
Compositions comprising anti-cd32b antibodies and methods of use thereof
|
WO2018237326A1
(en)
|
2017-06-22 |
2018-12-27 |
1AlMOONSHOT PHARMA LLC |
METHODS OF TREATING CANCER USING COMPOSITIONS COMPRISING AMLEXANOX AND IMMUNOMODULATORS
|
US11179457B2
(en)
|
2017-07-12 |
2021-11-23 |
Boehringer Ingelheim Animal Health USA Inc. |
Senecavirus a immunogenic compositions and methods thereof
|
EP3655430A1
(de)
|
2017-07-19 |
2020-05-27 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Antikörper und verfahren zur diagnose und behandlung von hepatitis-b-virusinfektionen
|
AU2018325528A1
(en)
|
2017-08-31 |
2020-04-16 |
Newport Laboratories, Inc. |
Streptococcus suis vaccines to protect against reproductive, nursery-age, and growing pig diseases and methods of making and use thereof
|
TW201923084A
(zh)
|
2017-09-23 |
2019-06-16 |
德商百靈佳殷格翰維美迪加股份有限公司 |
副黏液病毒科(paramyxoviridae)表現系統
|
EP3470429A1
(de)
|
2017-10-10 |
2019-04-17 |
Numab Innovation AG |
Auf pdl1 gerichtete antikörper und verfahren zur verwendung davon
|
EP3470428A1
(de)
|
2017-10-10 |
2019-04-17 |
Numab Innovation AG |
Anti cd137 antikörper und deren verwendung
|
MA50352A
(fr)
|
2017-10-10 |
2020-08-19 |
Numab Therapeutics AG |
Anticorps multispécifiques
|
EP3470426A1
(de)
|
2017-10-10 |
2019-04-17 |
Numab Therapeutics AG |
Multispezifischer antikörper
|
WO2019081983A1
(en)
|
2017-10-25 |
2019-05-02 |
Novartis Ag |
CD32B TARGETING ANTIBODIES AND METHODS OF USE
|
WO2019092027A1
(en)
|
2017-11-09 |
2019-05-16 |
Boehringer Ingelheim Vetmedica Gmbh |
Sapelovirus immunogenic compositions and uses thereof
|
WO2019126472A1
(en)
|
2017-12-22 |
2019-06-27 |
Genentech, Inc. |
Use of pilra binding agents for treatment of a disease
|
KR20200124713A
(ko)
|
2018-02-23 |
2020-11-03 |
베링거잉겔하임베트메디카게엠베하 |
외인성 펠라인 파라믹소바이러스 유전자를 발현하는 재조합 바이러스 벡터 시스템 및 이로부터 제조된 백신
|
EP3768307A1
(de)
|
2018-03-19 |
2021-01-27 |
Boehringer Ingelheim Vetmedica GmbH |
Neue ehv mit inaktiviertem ul18 und/oder ul8
|
US11596681B2
(en)
|
2018-03-19 |
2023-03-07 |
Boehringer Ingelheim Vetmedica Gmbh |
EHV insertion site UL43
|
EP3793596A1
(de)
|
2018-05-16 |
2021-03-24 |
MorphoSys AG |
Antikörper gegen glycoprotein vi
|
TW202015726A
(zh)
|
2018-05-30 |
2020-05-01 |
瑞士商諾華公司 |
Entpd2抗體、組合療法、及使用該等抗體和組合療法之方法
|
EP3816186A4
(de)
|
2018-06-29 |
2022-04-06 |
Suzhou Smartnuclide Biopharmaceutical Co., Ltd. |
Pd-l1-bindende polypeptide und verwendung davon
|
TW202026010A
(zh)
|
2018-09-20 |
2020-07-16 |
德商百靈佳殷格翰維美迪加股份有限公司 |
抗豬流行性下痢之鼻內載體疫苗
|
UY38407A
(es)
|
2018-10-15 |
2020-05-29 |
Novartis Ag |
Anticuerpos estabilizadores de trem2
|
US20210387020A1
(en)
|
2018-10-19 |
2021-12-16 |
University Of Rochester |
Immune modulators in combination with radiation treatment for advanced pancreatic cancer
|
US20210363509A1
(en)
|
2018-10-22 |
2021-11-25 |
University Of Rochester |
Genome Editing by Directed Non-Homologous DNA Insertion Using a Retroviral Integrase-Cas9 Fusion Protein
|
US20220089670A1
(en)
|
2018-12-28 |
2022-03-24 |
University Of Rochester |
Gene Therapy for BEST1 Dominant Mutations
|
JP7416451B2
(ja)
|
2019-01-14 |
2024-01-17 |
ユニバーシティ オブ ロチェスター |
CRISPR-Casによる標的化された核内RNA切断及びポリアデニル化
|
US20220118089A1
(en)
|
2019-02-25 |
2022-04-21 |
The University Of Chicago |
Methods and compositions for treating inflammatory and autoimmune conditions with ecm-affinity peptides linked to anti-inflammatory agents
|
EP3946445A2
(de)
|
2019-03-27 |
2022-02-09 |
Boehringer Ingelheim Vetmedica GmbH |
Immunogene zusammensetzungen und impfstoffe mit peptiden und proteinen des afrikanischen schweinepestvirus und verwendungen davon
|
AU2020256283A1
(en)
|
2019-04-04 |
2021-11-18 |
Boehringer lngelheim Vetmedica GMBH |
Porcine circovirus type 3 (PCV3) vaccines, and production and uses thereof
|
AU2020281535A1
(en)
|
2019-05-24 |
2022-01-27 |
Merck Patent Gmbh |
Combination therapies using CDK inhibitors
|
CA3144533A1
(en)
|
2019-06-03 |
2020-12-10 |
The University Of Chicago |
Methods and compositions for treating cancer with cancer-targeted adjuvants
|
JP7315259B2
(ja)
|
2019-07-01 |
2023-07-26 |
スジョウ・アルファマブ・カンパニー・リミテッド |
百日咳毒素結合タンパク質
|
US20220267773A1
(en)
|
2019-07-23 |
2022-08-25 |
University Of Rochester |
Targeted RNA cleavage with CRISPR-Cas
|
TW202124446A
(zh)
|
2019-09-18 |
2021-07-01 |
瑞士商諾華公司 |
與entpd2抗體之組合療法
|
JP2022548881A
(ja)
|
2019-09-18 |
2022-11-22 |
ノバルティス アーゲー |
Entpd2抗体、組合せ療法並びに抗体及び組合せ療法を使用する方法
|
CN115175680A
(zh)
|
2019-10-18 |
2022-10-11 |
加利福尼亚大学董事会 |
Plxdc激活剂及其用于治疗血管病症的用途
|
WO2021158982A2
(en)
|
2020-02-07 |
2021-08-12 |
University Of Rochester |
Targeted translation of rna with crispr-cas13 to enhance protein synthesis
|
CA3171831A1
(en)
|
2020-02-21 |
2021-08-26 |
Origimm Biotechnology Gmbh |
Propionibacterium acnes prophylactic and therapeutic immune treatment
|
KR20220154140A
(ko)
|
2020-03-13 |
2022-11-21 |
지앙수 헨그루이 파마슈티컬스 컴퍼니 리미티드 |
Pvrig 결합 단백질 및 이의 의학적 용도
|
JP2023519307A
(ja)
|
2020-03-27 |
2023-05-10 |
ユニバーシティ オブ ロチェスター |
Crispr-cas13によるウイルスrnaの標的化破壊
|
JP2023519344A
(ja)
|
2020-03-27 |
2023-05-10 |
ユニバーシティ オブ ロチェスター |
CRISPR-Cas13 crRNAアレイ
|
EP4143225A4
(de)
|
2020-04-27 |
2024-05-15 |
The Regents of the University of California |
Isoform-unabhängige antikörper gegen lipoprotein(a)
|
MX2022016337A
(es)
|
2020-06-17 |
2023-04-10 |
Boehringer Ingelheim Vetmedica Gmbh |
Vectores de hvt recombinantes que expresan hemaglutinina de influenza y composiciones inmunogenicas, su produccion y usos.
|
WO2022002233A1
(zh)
|
2020-07-03 |
2022-01-06 |
苏州康宁杰瑞生物科技有限公司 |
凝血因子xi(fxi)结合蛋白
|
CA3185589A1
(en)
|
2020-07-15 |
2022-01-20 |
Douglas Matthew ANDERSON |
Targeted rna cleavage with dcasl3-rnase fusion proteins
|
WO2022013787A1
(en)
|
2020-07-16 |
2022-01-20 |
Novartis Ag |
Anti-betacellulin antibodies, fragments thereof, and multi-specific binding molecules
|
WO2022017370A1
(zh)
|
2020-07-21 |
2022-01-27 |
苏州智核生物医药科技有限公司 |
Cd8结合多肽及其用途
|
WO2022043855A1
(en)
|
2020-08-26 |
2022-03-03 |
Pfizer Inc. |
Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
|
MX2023004342A
(es)
|
2020-10-20 |
2023-05-04 |
Hoffmann La Roche |
Politerapia de antagonistas de union al eje de pd-1 e inhibidores de lrrk2.
|
US20220168293A1
(en)
|
2020-12-02 |
2022-06-02 |
Pfizer Inc. |
Time to resolution of axitinib-related adverse events
|
KR20230157315A
(ko)
|
2021-01-28 |
2023-11-16 |
리제너론 파마슈티칼스 인코포레이티드 |
사이토카인 방출 증후군을 치료하기 위한 조성물 및 방법
|
EP4284510A1
(de)
|
2021-01-29 |
2023-12-06 |
Novartis AG |
Dosierungsschemata für anti-cd73- und anti-enpd2-antikörper und verwendungen davon
|
EP4046652A1
(de)
|
2021-02-23 |
2022-08-24 |
Johann Wolfgang Goethe-Universität Frankfurt |
Zusammensetzungen und verfahren zur diagnose, behandlung und vorbeugung der carriðn-krankheit
|
AU2022261125A1
(en)
|
2021-04-23 |
2023-11-23 |
University Of Rochester |
Genome editing by directed non-homologous dna insertion using a retroviral integrase-cas fusion protein and methods of treatment
|
TW202313045A
(zh)
|
2021-06-09 |
2023-04-01 |
瑞士商赫孚孟拉羅股份公司 |
用於癌症治療之組合療法
|
CA3231553A1
(en)
|
2021-09-15 |
2023-03-23 |
Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
Pharmaceutical composition comprising anti-pvrig/tigit bispecific antibody
|
TW202327595A
(zh)
|
2021-10-05 |
2023-07-16 |
美商輝瑞大藥廠 |
用於治療癌症之氮雜內醯胺化合物的組合
|
NL2031833B1
(en)
|
2022-05-11 |
2023-11-17 |
Univ Leiden |
Immunotherapeutic compositions and adjuvants
|
WO2023240458A1
(zh)
*
|
2022-06-14 |
2023-12-21 |
中国医学科学院病原生物学研究所 |
一种口蹄疫病毒多肽抑制剂及其应用
|
WO2024028794A1
(en)
|
2022-08-02 |
2024-02-08 |
Temple Therapeutics BV |
Methods for treating endometrial and ovarian hyperproliferative disorders
|
EP4316513A1
(de)
|
2022-08-02 |
2024-02-07 |
Consejo Superior de Investigaciones Científicas (CSIC) |
Neuer dna-sars-cov-2-impfstoff
|